|
|
|
|
| LEADER |
00936Cam#a2200301#a#4500 |
| 001 |
OMD010090 |
| 003 |
OMD |
| 005 |
20141104102851 |
| 008 |
t2009 mx a ||f |||| ||spa d |
| 005 |
20240422 091644 |
| 005 |
20240422 091657 |
| 022 |
# |
# |
|a 1234-56778
|
| 040 |
# |
# |
|a OMD
|b spa
|
| 060 |
# |
4 |
|a WQ
|b 240
|
| 092 |
# |
# |
|c WQ 240
|l BRI
|
| 100 |
1 |
# |
|a Briones Garduño, Jesús Carlos.
|
| 245 |
1 |
0 |
|a Preeclampsia /
|c Jesús Carlos Briones Garduño y Alejandro Reyes Fuentes.
|
| 260 |
# |
# |
|a México :
|b Alfil,
|c c2009.
|
| 300 |
# |
# |
|a xvi, 174 p. :
|b il.
|
| 650 |
# |
7 |
|a Complicaciones del embarazo
|2 Decs
|
| 650 |
# |
7 |
|a Preeclampsia/prevención & control
|2 Decs
|
| 650 |
# |
7 |
|a Mortalidad materna
|2 Decs
|
| 700 |
1 |
# |
|a Reyes Fuentes, Alejandro.
|
| 866 |
# |
0 |
|a 1 ej.
|
| 928 |
# |
# |
|a pre
|
| 928 |
# |
# |
|a enc
|
| 952 |
# |
# |
|p OMD33777
|t ej.1
|a OMD
|b OMD
|o WQ 240 BRI [SALA]
|7 1
|y IMP
|d 20100422
|f DON
|k Grupo Fármacos Especializados S.A. de C.V.
|
| 999 |
# |
# |
|a Claudia
|
